NCT00843882 2026-04-13Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and AnemiaNational Cancer Institute (NCI)Phase 3 Active not recruiting247 enrolled 19 charts
NCT00179621 2011-04-14Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q[31] AbnormalityCelgenePhase 3 Completed205 enrolled 25 charts